Otolaryngology Doctors in Menomonee Falls, WI Accepting Medicare

3 Otolaryngology doctors found. Showing 1 - 3

Casey Flanary, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: W129n7055 Northfield Dr, Otolaryngology, Menomonee Falls, WI 53051 Phone: 262-253-5400    Fax: 262-253-3700

Dr. Stephen Romeo, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: N84w16889 Menomonee Ave, Menomonee Falls, WI 53051 Phone: 262-251-7500

Richard J. Grunke, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: N84w16889 Menomonee Ave, Menomonee Falls, WI 53051 Phone: 262-251-7500    Fax: 262-251-7128

News Archive

Researchers decode brain maps of human color perception

Researchers at the National Eye Institute (NEI) have decoded brain maps of human color perception. The findings, published today in Current Biology, open a window into how color processing is organized in the brain, and how the brain recognizes and groups colors in the environment.

Roundup: Ore. says up to 200K could remain uninsured by 2019; High hopes for CO-OPs in Calif.

A 2010 report published by the Oregon Office of Health Policy Research estimates that 35 percent of currently people lacking insurance would remain uninsured by 2019, despite expanded coverage by the Affordable Care Act. The publication does not give the raw numbers of Oregonians with insurance versus those without. But comparing it with data released by Kaiser Family Foundation that same year - which says about 565,000 Oregonians currently lack insurance - it can be extrapolated that about 200,000 people will be uninsured in 2019.

Research shows probiotics can help combat anxiety and depression

Previous research has tied mental health issues and developmental disorders to gut health. Now, a team of British scientists has shown that foods that broaden the profile of helpful bacteria in the gut, which are collectively known as probiotics, can help ease anxiety and depression.

FDA approves changes to REMS for Nplate and Promacta

The approval of changes to the Risk Evaluation and Mitigation Strategies (REMS) for both Nplate (romiplostim) and Promacta (eltrombopag) was announced by the U.S. Food and Drug Administration.

Read more Medical News

› Verified 1 days ago